Search

everythinglearnresearchcommunity

for

Search:↓

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Six African American women experienced hair loss after switching to a new HIV medication.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

A possible link exists between minimal change nephrotic syndrome and complete hair loss.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Psoriasis can cause temporary or permanent hair loss.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Bimatoprost solution is effective and safe for long-term use in treating eyelash thinning.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Etretinate treatment changed hair growth patterns in many patients.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

High-dose radiation speeds up aging in skin stem cells.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.